Noninvasive detection of pancreatic ductal adenocarcinoma in high-risk patients using miRNA from urinary extracellular vesicles.
Saved in:
| Title: | Noninvasive detection of pancreatic ductal adenocarcinoma in high-risk patients using miRNA from urinary extracellular vesicles. |
|---|---|
| Authors: | Kawase T; Department of Gastroenterology and Hepatology, Kawasaki Medical School, Kurashiki, Japan.; Department of Gastroenterology, Hokuto Hospital, Obihiro, Japan., Kato Y; Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.; Department of Pathology and Genetics, Laboratory of Cancer Medical Science, Hokuto Hospital, Obihiro, Japan., Nishihara H; Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan., Baba S; Department of Pathology and Genetics, Laboratory of Cancer Medical Science, Hokuto Hospital, Obihiro, Japan., Kawasaki T; Department of Health Screenings, Hokuto Hospital, Obihiro, Japan., Kurahara H; Department of Digestive Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Oi H; Department of Digestive Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, Tokyo Women's Medical University, Tokyo, Japan., Okada M; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan., Satake T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Igawa YS; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Yoshida T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Kita J; Department of Surgery, Kumagaya General Hospital, Kumagaya, Saitama, Japan., Imura J; Department of Diagnostic Pathology, Kumagaya General Hospital, Kumagaya, Saitama, Japan., Kinoshita K; Department of Surgery, Kumagaya General Hospital, Kumagaya, Saitama, Japan., Yokoyama M; Department of Surgery, Kumagaya General Hospital, Kumagaya, Saitama, Japan.; Department of Surgery, Division of Transplant Surgery, Virginia Commonwealth University, Richmond, VA, United States., Satomura A; Craif Inc., Nagoya, Japan.; Institute of Innovation for Future Society, Nagoya University, Aichi, Japan., Takayama K; Craif Inc., Nagoya, Japan., Mikami M; Craif Inc., Nagoya, Japan.; Institute of Innovation for Future Society, Nagoya University, Aichi, Japan., Nishiyama Y; Craif Inc., Nagoya, Japan., Mizunuma M; Craif Inc., Nagoya, Japan., Ichikawa Y; Craif Inc., Nagoya, Japan.; Institute of Innovation for Future Society, Nagoya University, Aichi, Japan., Yoshida K; Department of Gastroenterology and Hepatology, Kawasaki Medical School, Kurashiki, Japan. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Jan 27; Vol. 15, pp. 1682072. Date of Electronic Publication: 2026 Jan 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1682072 |
